Sign in to continue:

Wednesday, April 1st, 2026

Day: March 9, 2026

HBM Holdings Receives NMPA Approval for Investigational New Drug HBM7575 for Atopic Dermatitis 1

HBM Holdings Limited: IND Approval for HBM7575/SKB575 for At...